NEW YORK – 10x Genomics reported after the close of the market on Tuesday a 23 percent decrease in second quarter revenues, attributable to customer lab closures due to the COVID-19 pandemic.
For the three months ended June 30, 2020 the Pleasanton, California-based single-cell and spatial analysis technologies firm reported $42.9 million in revenues, down from $55.8 million in the prior-year period, beating the consensus Wall Street estimate of $29.6 million.